ACAdrian J. Correa

Adrian J. Correa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adrian J. Correa has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    CRTC1::TRIM11 fusion (CMTCT) tumor with novel presentation in the nasal cavity of three patients

    by Bushra Sayeed, Mark G. Evans, Adam Bedeir, Anthony Crymes, Mark Swanson, Adrian J. Correa, Elías Sobrino-Najul, Camille Santiago-Negrón, María Correa-Rivas, Jeffson Chung, et al.

    Purpose: CRTC1::TRIM11 cutaneous melanocytic tumors are a recently described uncommon entity almost exclusively reported as arising in the skin with fewer than 70 described cases and no dedicated reports of tumors arising in the sinonasal cavity (SNC). We identified 3 cases arising in the SNC with similar morphology and immunophenotype, all harboring CRTC1::TRIM11 fusion. We present the clinical, histological, immunophenotype, and molecular profile of these tumors and compare our tumors with those previously reported in the literature and provide practical guidance for evaluating tumors in the SNC with undifferentiated, neuroendocrine, or melanocytic phenotype. Methods: Formalin-fixed, paraffin embedded tissue sections of the patients’ tumors were examined and compared with routinely stained sections and by immunohistochemistry. Whole exome/whole transcriptome sequencing revealing CRTC1::TRIM11 fusions in each case was performed at Caris ® Life Sciences. Results: The patients were 34, 48, and 69 years of age, 2 females and 1 male. All tumors originated in the nasal cavity and hard palate. Original diagnoses were S100-negative granular cell tumor, poorly differentiated carcinoma and mucosal melanoma. All tumors demonstrated highly cellular proliferations of round/ovoid cells arranged in vague organoid clusters. Individual cells had moderate eosinophilic granular cytoplasm and round nuclei containing dispersed and granular chromatin with visible nucleoli resembling neuroendocrine tumors. The neural markers synaptophysin and chromogranin were negative, however, tumors expressed PGP9.5 and NCAM in 2 cases. All cases expressed SOX10 in a diffuse fashion but negative for S100, Melan-A, HMB-45. CRTC1::TRIM11 fusion was detected in all cases. Conclusions: This recently described CRTC1::TRIM11 fusion-driven tumor almost exclusively described in cutaneous sites, hence the current designation as cutaneous melanocytic tumor with CRTC1::TRIM11 fusion (CMTCT), can arise in the nasal cavity and should be considered in the differential diagnoses of aggressive tumors with similar morphologies in the SNC that include mucosal melanoma, sinonasal undifferentiated carcinoma, and neuroectodermal and neuroendocrine carcinomas.

  • Near Complete Necrosis of a Giant Cell Tumor After Treatment with Denosumab

    by Elke R. Ahlmann, Lingjun Wang, Adrian J. Correa, Alexander N. Fedenko

  • Open Access

    Establishment and Characterization of a Novel Head and Neck Squamous Cell Carcinoma Cell Line USC-HN1

    by Daniel J Liebertz, Melissa G Lechner, Rizwan Masood, Uttam K Sinha, Jing Han, Raj K Puri, Adrian J Correa, Alan L Epstein

    Background: Head and neck squamous cell carcinoma (HNSCC) is an aggressive and lethal malignancy. Publically available cell lines are mostly of lingual origin, or have not been carefully characterized. Detailed characterization of novel HNSCC cell lines is needed in order to provide researchers a concrete keystone on which to build their investigations. Methods: The USC-HN1 cell line was established from a primary maxillary HNSCC biopsy explant in tissue culture. The immortalized cells were then further characterized by heterotransplantation in Nude mice; immunohistochemical staining for relevant HNSCC biomarkers; flow cytometry for surface markers; cytogenetic karyotypic analysis; human papillomavirus and Epstein-Barr virus screening; qRT-PCR for oncogene and cytokine analysis; investigation of activated, cleaved Notch1 levels; and detailed 35,000 gene microarray analysis. Results: Characterization experiments confirmed the human HNSCC origin of USC-HN1, including a phenotype similar to the original tumor. Viral screening revealed no HPV or EBV infection, while western blotting displayed significant upregulation of activated, cleaved Notch1. Conclusions: USC-HN1, a novel immortalized cell line has been derived from a maxillary HNSCC. Characterization studies have shown that the cell line is of HNSCC origin and displays many of the same markers previously reported in the literature. USC-HN1 is available for public research and will further the investigation of HNSCC and the development of new therapeutic modalities.